Full name
OXFORD MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice activities
46.46.Z - Wholesale of pharmaceutical goods
46.90.Z - Non-specialised wholesale trade
62.09.Z - Other information technology and computer service activities
72.19.Z - Other research and experimental development on natural sciences and engineering
78 - Employment activities
85.60.Z - Educational support activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 55 | -241,6 | 55,7 | 123,1 |
EBITDA | 55 | -233,9 | 74,7 | 132 |
Short time liabilities | 5 | 216,2 | 281 | 30 |
Equity capital | 55 | -186,6 | -130,9 | 29,9 |
Operating profit (EBIT) | 55 | -238,9 | 62,6 | 126,2 |
Assets | 60,1 | 29,6 | 150,1 | 407,5 |
Net profit (loss) | 50 | -241,6 | 55,7 | 123,1 |
Cash | 0,1 | 0,3 | 6,1 | 2299,9 |
Net income from sale | 106,4 | 43,8 | 348,8 | 695,5 |
Liabilities and provisions for liabilities | 5 | 216,2 | 281 | 30 |
Working assets | 60,1 | 29,6 | 150,1 | 407,5 |
Depreciation | 0 | 5 | 12,1 | 142,3 |
% | % | % | p.p. | |
Profitability of capital | 90,9 | 129,5 | -42,6 | -172,1 |
Equity capital to total assets | 91,6 | -631 | -87,2 | 543,8 |
Gross profit margin | 51,7 | -551 | 16 | 567 |
EBITDA Margin | 51,7 | -533,4 | 21,4 | 554,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 17 | 1800 | 294 | -1506 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane